Terapia Génica del Cáncer
TGC
Hôpital Européen Georges-Pompidou
París, FranciaHôpital Européen Georges-Pompidou-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2016
-
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer
Journal of Clinical Oncology, Vol. 34, Núm. 15, pp. 1723-1731